Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 48

Sort by

Sort Order Select

Journal Articles

Superior Outcome of Bone Marrow Transplantation Using Fludarabine and Cyclophosphamide with ATG over Fludarabine and Cyclophosphamide without ATG Conditioning Regimen in Severe Aplastic Anemia

Blood (2023) 142 (Supplement 1): 6951.

https://doi.org/10.1182/blood-2023-182333

Published: 2023

Journal Articles

Sustained Efficacy and Safety with Asciminib (ASC) after Almost 4 Years of Median Follow-up from Ascembl, a Phase 3 Study of ASC Vs Bosutinib (BOS) in Patients (Pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) after ≥2 Prior Tyrosine Kinase Inhibitors (TKIs): An End of Study Treatment (EOS Tx) Update, Including Results from Switch Population

Blood (2023) 142 (Supplement 1): 4536.

https://doi.org/10.1182/blood-2023-186854

Published: 2023

Journal Articles

Molecular Characterisation and Outcomes of 363 Adolescent and Young Adults with AML in Saudi Arabia Risk Stratified By PCR and NGS-Based Testing

Blood (2023) 142 (Supplement 1): 7433.

https://doi.org/10.1182/blood-2023-187940

Published: 2023

Journal Articles

The Outcome of Tisagenlecleucel (Tisa-Cel) Vs Axicabtagene Ciloleucel (Axi-Cel) CD-19 CAR-T Cell Therapy in Relapsed/Refractory NHL, Real World Data, Single Institution Experience

Reem Alasbali, Abdulrahman Nasiri, Alfadil Adam, Saud Alhayli, Naeem A. Chaudhri, Alfadel Alshaibani, Abdulwahab Albabtain, Hadeel Samarkandi, Ayman Saad, Abdullah Alamer, Tusneem Ahmed M Elhassan, Hazza A. Alzahrani, Syed Osman Ahmed, Walid Rasheed, Riad Elfakih, Mahmoud Aljurf, ALI D Alahmari

Blood (2023) 142 (Supplement 1): 6936.

https://doi.org/10.1182/blood-2023-182580

Published: 2023

Journal Articles

A Deep Learning Framework for Classification of Immature White Blood Cells in Acute Myeloid Leukemia Using Convolutional Autoencoder and Transfer-Learning Ensemble

Tusneem Ahmed M Elhassan, Mohd Shafry Mohd Rahim, Ahmed Hamza Osman, Naeem A. Chaudhri, Mahmoud Aljurf

Blood (2023) 142 (Supplement 1): 7290.

https://doi.org/10.1182/blood-2023-188817

Published: 2023

Journal Articles

Allogeneic Stem Cell Transplantation in Adolescent and Adult Patients with Acute T Cell Lymphoblastic Leukemia / Lymphoma : Single Center Experience of 143 Patients

Blood (2023) 142 (Supplement 1): 7101.

https://doi.org/10.1182/blood-2023-185676

Published: 2023

Journal Articles

Clinical Characterization, Cancer Incidence and Long-Term Outcomes of Fanconi Anemia Patients : A Single Center Analysis of 97 Patients

Blood (2022) 140 (Supplement 1): 11471–11473.

https://doi.org/10.1182/blood-2022-162734

Published: 2022

Journal Articles

Allogeneic Hematopoietic Cell Transplant Yields Long Term Disease Free Survival in a Significant Number of Patients with Classic Hodgkin Lymphoma

Blood (2022) 140 (Supplement 1): 12969–12970.

https://doi.org/10.1182/blood-2022-164820

Published: 2022

Journal Articles

Venetoclax Treatment Outcomes and Patterns of Use in Relapsed/Refractory Chronic Lymphocytic Leukemia Under Routine Clinical Practice in Saudi Arabia and Gulf Countries (VICTORY Study)

Tarek Abouzeid, Taimoor Hussain, Sameer AlAmoudi, Ahmad Absi, Arif Alam, Mansour Alfayez, Ahmad Alhuraiji, Mohammed Aldarweesh, Husni Al-Hateeti, Gehad El Ashal, Omar Hussein, Ali Anwar, Mohamed Gouda Ismail, Leila Bereksi, Haidy Abdellatif, Yasser Nour, Abdallah Saad, Naeem A. Chaudhri

Blood (2022) 140 (Supplement 1): 12397–12399.

https://doi.org/10.1182/blood-2022-168049

Published: 2022

Journal Articles

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia

Molly Tokaz, Helen Baldomero, Andrew J Cowan, Wael Saber, Hildegard T. Greinix, Mickey Koh, Nicolaus Kröger, Mohamad Mohty, Sebastian Galeano, Shinichiro Okamoto, Naeem A. Chaudhri, Amado J Karduss, Fabio Ciceri, Vergilio Rensi Colturato, Selim Corbacioglu, Alaa M. Elhaddad, Lisa Force, Cristobal Augusto Frutos Ortiz, Andres Gomez-De Leon, Nada Hamad, Nelson Hamerschlak, Naya He, Aloysius YL Ho, Xiao-Jun Huang, Benjamin Jacobs, Heeje Kim, Minako Iida, Leslie E. Lehmann, Régis Peffault de Latour, Mary-Elizabeth M. Percival, Walid Rasheed, Kirk R. Schultz, Adriana Seber, Bor-Sheng Ko, Anderson Simione, Alok Srivastava, Jeff Szer, William A. Wood, Yoshihisa Kodera, Arnon Nagler, John A Snowden, Daniel J. Weisdorf, Jakob R. Passweg, Marcelo C Pasquini, Anna Sureda, Yoshiko Atsuta, Mahmoud Aljurf, Dietger Niederwieser, Martina Perdomo

Blood (2022) 140 (Supplement 1): 8146–8149.

https://doi.org/10.1182/blood-2022-158338

Published: 2022

Journal Articles

Successful Restoration of Nivolumab Efficacy Post Allogeneic Stem Cell Transplantation in Hodgkin's Lymphoma

Khawlah Farhan, Abdulwahab Albabtain, Saud Alhayli, Walid Rasheed, Alfadel Alshaibani, Naeem A. Chaudhri, Ali Alahmari, Mahmoud Aljurf, Riad El Fakih

Blood (2022) 140 (Supplement 1): 12048–12049.

https://doi.org/10.1182/blood-2022-158953

Published: 2022

Journal Articles

Utility and Validity of Hematopoietic Cell Transplantation-Comorbidity Index (HCT-CI) in Predicting Overall Survival and Non-Relapse Mortality in Adolescent and Young Adult Population

Blood (2022) 140 (Supplement 1): 10566–10567.

https://doi.org/10.1182/blood-2022-167509

Published: 2022

Journal Articles

Sequential Fludarabine, Ara-C, Etoposide (FLAV) Followed By Fludarabine/ Busulfan Reduced Toxicity Conditioning Is Safe and Effective Salvage for Adult Patients with Refractory Acute Myeloid Leukemia and High Risk Myelodysplasia

Blood (2021) 138 (Supplement 1): 1851.

https://doi.org/10.1182/blood-2021-152602

Published: 2021

Journal Articles

Efficacy and Safety Results from Ascembl, a Multicenter, Open-Label, Phase 3 Study of Asciminib, a First-in-Class STAMP Inhibitor, Vs Bosutinib in Patients with Chronic Myeloid Leukemia in Chronic Phase after ≥2 Prior Tyrosine Kinase Inhibitors: Update after 48 Weeks

Blood (2021) 138 (Supplement 1): 310.

https://doi.org/10.1182/blood-2021-152561

Published: 2021

Journal Articles

Efficacy and Safety Results from ASCEMBL, a Multicenter, Open-Label, Phase 3 Study of Asciminib, a First-in-Class STAMP Inhibitor, vs Bosutinib (BOS) in Patients (Pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Previously Treated with ≥2 Tyrosine Kinase Inhibitors (TKIs

Blood (2020) 136 (Supplement_2): LBA-4.

https://doi.org/10.1182/blood-2020-143816

Published: 2020

Journal Articles

The Impact of Early Post-Transplant Cyclosporine Induced Acute Nephrotoxicity on Long Term Renal Function in 2-Year Survivors of Allogeneic Hematopoietic Stem Cell Transplantation: A Cohort Retrospective Study

Reem Alharbi, Mahmoud Aljurf, MD, Raid El Fakih, MD, Mohammad Al Nahedh, PharmD, Majed Huessein, MD, Zubeir Ahmed Nurgat, BSc, MSc, Almohareb Fahad, MD, Naeem A. Chaudhri, MD, Fahad Z. Alsharif, MB, MD, Hazza A. Alzahrani, MD, Walid Rasheed, MB, ChB, FRACP, FRCPA, Amr Suleiman Hanbali, MD, Marwan Shaheen, MD, Feras Al Fraih, MD, Saud Alhayli, MD, Riad Youniss, Shahrukh Hashmi, MD, Syed Osman Ahmed, BSc, FRCPath, MBBS, MRCP

Blood (2018) 132 (Supplement 1): 3358.

https://doi.org/10.1182/blood-2018-99-114667

Published: 2018

Journal Articles

Proteomics Analysis Reveals Protein Panels That Are Associated with Prediction to Tyrosine Kinase Inhibitors Response, Bone Marrow Transplant, Survival and Disease Outcome of Chronic Myeloid Leukemia Patients

Ayodele Alaiya, MPH, MBBS, PhD, Mahmoud Aljurf, MD, Zakia Shinwari, MSc, Fahad Z. Alsharif, MB, MD, Hazza A. Alzahrani, MD, Syed Osman Ahmed, BSc, FRCPath, MBBS, MRCP, Tarek Owaidah, MD FRCPA, Amr Suleiman Hanbali, MD, Marwan Shaheen, MD, Feras Al Fraih, MD, Riad Elfakih, MD, Saud Alhayli, MD, Shahrukh Hashmi, MD, Walid Rasheed, MB, ChB, FRACP, FRCPA, Fahed Almhareb, MBBS, FACP, Naeem A. Chaudhri, MD

Blood (2018) 132 (Supplement 1): 5434.

https://doi.org/10.1182/blood-2018-99-118754

Published: 2018

Journal Articles

A Clinical, Genomic and Proteomic Approach for the Characterization of Fanconi Anemia in Adolescent and Young Adult (AYA) Patients : A Single Center Study of 55 Patients from a National Bone Marrow Failure Referral Center

Blood (2018) 132 (Supplement 1): 2594.

https://doi.org/10.1182/blood-2018-99-114639

Published: 2018

Journal Articles

Impact of Anti-Hepatitis B Core Following Allogeneic Bone Marrow Transplantation; Single Center Study of 489 Patients

Muhned Alhumaid, MD, Syed Osman Ali Ahmed, BSc, FRCPath, MBBS, MRCP, Fahad Al Mohareb, MD, Fahad Z. Alsharif, MB,MD, Hazzaa Alzahrani, MD, Naeem A. Chaudhri, MD, Raid El Fakih, MD, Amr Hanbali, MD, Shahrukh K. Hashmi, MDMPH, Said Yousuf Ahmed, MD, Walid Rasheed, MB, CHB, FRACP, FRCPA, Marwan Shaheen, MD, Tusneem Elhassan, MSc, Feras Abdulaziz Alfraih, MD

Blood (2017) 130 (Supplement 1): 5498.

https://doi.org/10.1182/blood.V130.Suppl_1.5498.5498

Published: 2017

Journal Articles

Development of Unique Molecular Signatures for Bone Marrow Failure Syndromes

Ayodele Alaiya, MBBS,MPH,PhDFRCPath, Zakia Shinwari, MSc, Hazza Alzahrani, MD, Tarek Owaidah, MD, Fahad Al Mohareb, MD, Fahad Z. Alsharif, MB,MD, Randa M Alnounou, MD, Walid Rasheed, MB, CHB, FRACP, FRCPA, Raid El Fakih, MD, Amr Hanbali, MD, Marwan Shaheen, MD, Feras Abdulaziz Alfraih, MD, Hashmi Shahrukh, MD, Majed Dasouki, MD, Naeem A. Chaudhri, MD, Syed Osman Ali Ahmed, BSc, FRCPath, MBBS, MRCP, Mahmoud Aljurf

Blood (2017) 130 (Supplement 1): 2465.

https://doi.org/10.1182/blood.V130.Suppl_1.2465.2465

Published: 2017

NARROW

Superior Outcome of Bone Marrow Transplantation Using Fludarabine and Cyclophosphamide with ATG over Fludarabine and Cyclophosphamide without ATG Conditioning Regimen in Severe Aplastic Anemia

Molecular Characterisation and Outcomes of 363 Adolescent and Young Adults with AML in Saudi Arabia Risk Stratified By PCR and NGS-Based Testing

The Outcome of Tisagenlecleucel (Tisa-Cel) Vs Axicabtagene Ciloleucel (Axi-Cel) CD-19 CAR-T Cell Therapy in Relapsed/Refractory NHL, Real World Data, Single Institution Experience

A Deep Learning Framework for Classification of Immature White Blood Cells in Acute Myeloid Leukemia Using Convolutional Autoencoder and Transfer-Learning Ensemble

Allogeneic Stem Cell Transplantation in Adolescent and Adult Patients with Acute T Cell Lymphoblastic Leukemia / Lymphoma : Single Center Experience of 143 Patients

Clinical Characterization, Cancer Incidence and Long-Term Outcomes of Fanconi Anemia Patients : A Single Center Analysis of 97 Patients

Allogeneic Hematopoietic Cell Transplant Yields Long Term Disease Free Survival in a Significant Number of Patients with Classic Hodgkin Lymphoma

Venetoclax Treatment Outcomes and Patterns of Use in Relapsed/Refractory Chronic Lymphocytic Leukemia Under Routine Clinical Practice in Saudi Arabia and Gulf Countries (VICTORY Study)

An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia

Successful Restoration of Nivolumab Efficacy Post Allogeneic Stem Cell Transplantation in Hodgkin's Lymphoma

Utility and Validity of Hematopoietic Cell Transplantation-Comorbidity Index (HCT-CI) in Predicting Overall Survival and Non-Relapse Mortality in Adolescent and Young Adult Population

Sequential Fludarabine, Ara-C, Etoposide (FLAV) Followed By Fludarabine/ Busulfan Reduced Toxicity Conditioning Is Safe and Effective Salvage for Adult Patients with Refractory Acute Myeloid Leukemia and High Risk Myelodysplasia

Efficacy and Safety Results from Ascembl, a Multicenter, Open-Label, Phase 3 Study of Asciminib, a First-in-Class STAMP Inhibitor, Vs Bosutinib in Patients with Chronic Myeloid Leukemia in Chronic Phase after ≥2 Prior Tyrosine Kinase Inhibitors: Update after 48 Weeks

Efficacy and Safety Results from ASCEMBL, a Multicenter, Open-Label, Phase 3 Study of Asciminib, a First-in-Class STAMP Inhibitor, vs Bosutinib (BOS) in Patients (Pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Previously Treated with ≥2 Tyrosine Kinase Inhibitors (TKIs

The Impact of Early Post-Transplant Cyclosporine Induced Acute Nephrotoxicity on Long Term Renal Function in 2-Year Survivors of Allogeneic Hematopoietic Stem Cell Transplantation: A Cohort Retrospective Study

Proteomics Analysis Reveals Protein Panels That Are Associated with Prediction to Tyrosine Kinase Inhibitors Response, Bone Marrow Transplant, Survival and Disease Outcome of Chronic Myeloid Leukemia Patients

A Clinical, Genomic and Proteomic Approach for the Characterization of Fanconi Anemia in Adolescent and Young Adult (AYA) Patients : A Single Center Study of 55 Patients from a National Bone Marrow Failure Referral Center

Impact of Anti-Hepatitis B Core Following Allogeneic Bone Marrow Transplantation; Single Center Study of 489 Patients

Development of Unique Molecular Signatures for Bone Marrow Failure Syndromes

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only